18F-PSMA-1007 PET/CT 发现的无症状前列腺癌直肠黏膜转移
一例65岁前列腺癌患者行18F-PSMA-1007 PET/CT分期,原发灶、膀胱、精囊腺及直肠见强烈18F-PSMA摄取,PET/CT显示直肠壁均匀圆形活性增高,最终诊断为前列腺癌直肠黏膜转移。该病例提示18F-PSMA PET/CT可能有助于定位前列腺癌罕见转移灶,对早期分期有潜在价值。
要点
- 前列腺癌直肠黏膜转移属较罕见转移部位,导致临床分期更高、预后更差。
- 65岁前列腺癌患者18F-PSMA-1007 PET/CT分期见原发灶、膀胱、精囊腺及直肠强烈摄取。
- PET/CT显示直肠壁均匀圆形活性增高,最终诊断为前列腺癌直肠黏膜转移。
核心结论
- 该病例提示18F-PSMA PET/CT可能有助于定位前列腺癌罕见转移灶,对早期分期有潜在价值。
研究设计与样本
- 本文为病例报告,报道一例65岁前列腺癌患者行18F-PSMA-1007 PET/CT分期。
主要发现
- 18F-PSMA摄取强烈见于原发灶、膀胱、相邻精囊腺及直肠。
- PET/CT显示直肠壁均匀圆形活性增高,最终诊断为前列腺癌直肠黏膜转移。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate cancer metastasis to the rectal mucosa, a relatively rare metastatic site, leads to a higher clinical stage and poorer prognosis. A 65-year-old man with prostate cancer underwent 18 F-prostate-specific membrane antigen (PSMA) PET/CT for staging. Intense 18 F-PSMA uptake occurred at the primary lesion, bladder, adjacent seminal vesicle, and rectum. PET/CT imaging revealed increased homogeneous round activity of the rectal wall. The final diagnosis was prostate cancer metastasis to the rectal mucosa. This case suggested that 18 F-PSMA PET/CT may assist in locating rare metastases of prostate cancer, with potential value for early staging.
引用
- Wang S, Cheng Z, Du B, et al. Asymptomatic Prostate Cancer Metastasis in Rectal Mucosa Revealed by 18 F-PSMA-1007 PET/CT. Clin Nucl Med. 2023. PMID: 36728159. doi:10.1097/RLU.0000000000004560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。